Screener
Pulse Biosciences, Inc. PLSE Business Segments — Sales & Marketing
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Pulse Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:SellingAndMarketingExpense.
The source filing: Pulse Biosciences, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:23 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-026288
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Cross platform research and engineering2 | 6,078 | 4,585 | 11,258 | 8,535 |
| R&D manufacturing and engineering3 | 3,201 | 2,941 | 5,550 | 4,736 |
| Clinical and regulatory4 | 5,127 | 2,183 | 8,387 | 3,943 |
| General and administrative5 | 4,548 | 2,742 | 8,490 | 5,461 |
| Sales and marketing6 | 1,279 | 2,362 | 3,607 | 4,218 |
| Other segment items7 | 5,228 | 5,462 | 7,394 | 11,426 |
| Total other income, net | (615) | (1,107) | (1,184) | (2,356) |
| Net loss | $(24,657) | $(19,168) | $(43,238) | $(35,963) |
Document
FAQ
- What is Pulse Biosciences, Inc.'s business segments — sales & marketing?
- Pulse Biosciences, Inc. (PLSE) reported business segments — sales & marketing of $1.28M in Q2 2026.
- What does business segments — sales & marketing mean?
- This represents the costs associated with promoting, selling, and distributing the company's products to healthcare providers and institutions. It reflects the company's investment in commercialization efforts and market penetration strategies.
Ask your AI about Pulse Biosciences, Inc.'s business segments — sales & marketing.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude